Prolonged ciprofloxacin therapy fails to prevent reactivation tuberculosis

Clinical Infectious Diseases

Volumn 27, Issue 4, 1998, Pages 913-914

  Lalonde, Richard G ^a,b   Barkun, Jeffrey ^b  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CIPROFLOXACIN; COTRIMOXAZOLE; ETHAMBUTOL; FLUOROURACIL; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; METHYLPREDNISOLONE; MITOMYCIN C; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; TACROLIMUS; THYMOCYTE ANTIBODY; TUBERCULOSTATIC AGENT;

AGED; ARTICLE; BILE DUCT CARCINOMA; CASE REPORT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; LIVER TRANSPLANTATION; LUNG LAVAGE; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RADIOTHERAPY; RECURRENT INFECTION; SCLEROSING CHOLANGITIS; TOXIC HEPATITIS; TUBERCULOSIS;

EID: 2442758016     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/517174     Document Type: Article

References (8)

1. International Union Against Tuberculosis Committee on Prophylaxis. Bull World Health Organ 1982; 60:555-64.
2. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council. A double-blind placebo controlled clinical trial of three antituberculous chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Respir Dis 1992; 145:36-41.
3. Nolan CM, Aitken ML, Elarth AM, Anderson KM, Miller WF. Active tuberculosis after isoniazid chemoprophylaxis of Southeast Asian refugees. Am Rev Respir Dis 1986; 133:431-6.
4. Centers for Disease Control and Prevention. Management of persons exposed to multidrug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep 1992; 41:61-71.
5. Yew WW, Piddock LJV, Li MSK, Lyon D, Chan CY, Cheng AFB. In vitro activity of quinolones and macrolides against mycobacteria. J Antimicrob Chemother 1994; 34:343-51.
6. Alangaden GJ, Lerner SA. The clinical use of fluoroquinolones for the treatment of mycobacterial diseases. Clin Infect Dis 1997; 25:1213-21.
7. Hooper DC, Wolfson JS. Fluoroquinolone antimicrobial agents. New Engl J Med 1991; 324:384-94.
8. Kennedy N, Berger L, Curram J, et al. Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis. Clin Infect Dis 1996; 22:827-33.